A significant breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor suppressor protein is frequently inactivated in many kinds of cancer, leading https://bookmarkick.com/story21996423/nanobodies-revive-tumor-suppressor-p53-the-promising-approach-for-tumor-therapy